Cell & Gene Therapy Scientist — AI Research (Remote)

RecruitSeq; United States; Remote; USD 140,000 - 180,000; Full time

Benefits offered by this job

Equity

Benefits

Job summary

RecruitSeq is seeking a Scientist, Cell and Gene Therapy (AI Research) in San Francisco or remote to join a team that evaluates how AI supports decisions in cell therapy, gene therapy, and RNA drug programs. This is a full-time W2 position with benefits and equity.

The ideal candidate has an MS or PhD with direct experience on therapeutic programs and can explain how experimental results guided the next steps. Collaboration with scientists and engineers to assess AI agents is essential.

Qualifications

• MS/PhD or equivalent professional experience in a therapeutic program (cell/gene therapy, genome editing, or RNA drugs).
• Ability to walk through results and show how evidence guided candidate selection and study design.
• Experience interpreting evidence relevant to modality, including safety and exposure signals.

Responsibilities

• Create case studies from cell therapy, gene therapy, or genetic medicine programs.
• Frame decisions using experimental results, balancing potency and safety considerations.
• Collaborate with scientists and engineers to evaluate AI agents’ approach to decisions and identify overlooked evidence.
• Write concise assessments explaining support for recommendations and what evidence could change conclusions.

Skills

MS/PhD or equivalent

Therapeutic program experience

AI research in science

Scientific writing

Education

MS/PhD in a relevant field

Job description

RecruitSeq is seeking a Scientist, Cell and Gene Therapy (AI Research) in San Francisco or remote to join a team that evaluates how AI supports decisions in cell therapy, gene therapy, and RNA drug programs. This is a full-time W2 position with benefits and equity.

The ideal candidate has an MS or PhD with direct experience on therapeutic programs and can explain how experimental results guided the next steps. Collaboration with scientists and engineers to assess AI agents is essential.